{{Rsnum
|rsid=10183914
|Gene=NFE2L2
|Chromosome=2
|position=177232938
|Orientation=plus
|GMAF=0.2557
|Gene_s=NFE2L2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 41.1 | 42.9 | 16.1
| HCB | 86.8 | 13.2 | 0.0
| JPT | 94.6 | 5.4 | 0.0
| YRI | 36.7 | 55.8 | 7.5
| ASW | 43.9 | 42.1 | 14.0
| CHB | 86.8 | 13.2 | 0.0
| CHD | 78.0 | 22.0 | 0.0
| GIH | 78.2 | 20.8 | 1.0
| LWK | 51.8 | 40.0 | 8.2
| MEX | 62.1 | 34.5 | 3.4
| MKK | 48.1 | 41.7 | 10.3
| TSI | 37.3 | 51.0 | 11.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=24528044
|Title=Association of NRF2 Polymorphism with Cholangiocarcinoma Prognosis in Thai Patients
}}

{{PMID Auto
|PMID=20196834
|Title=Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}